MedTrace Logo

The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure

NCT00234130 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-06-03

No results posted yet for this study

Summary

This study will determine whether a new form of home hemodialysis carried out at night during sleep reduces blood levels of hormone-like substances called cytokines that may cause fatigue and increase blood fats and sugar. Participants will stay twice in the Rockefeller Hospital and receive a standard diet and blood testing. Training for nocturnal hemodialysis will be provided at the nearby Manhattan Dialysis Center of The Rogosin Institute, affiliated with The Rockefeller University.

Conditions

  • End-Stage Renal Disease

Interventions

PROCEDURE

nocturnal vs conventional dialysis

Sponsors & Collaborators

  • The Rogosin Institute

    collaborator OTHER

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Lisa C. Hudgins, MD · Rockefeller University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Primary Completion
2006-05-31
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00234130 on ClinicalTrials.gov